ePrescription Bank Card

Looks like a credit card. Operates like a credit card with a chip and pin. The difference is this is a Patient managed repeat prescription card. Many patients have been on the same asthma drugs or HRT for years, yet the still have to go to GP every 56 days for their repeat (some may be lucky enough to be on CMS Serial Scripts and could get a few more weeks - not if you are on HRT though!) Premise is you are on repeats until GP STOPS the repeat. Patient presents their ePrescription Bank Card to any chemist in Scotland - card reader connects to existing national pharmacy message store...just like your bank says you can have funds, you can have your repeat drugs. This is because your GP has authorised long term repeat and you have not reached your med review date or your chronic disease recall date. Patient issued with 2 MTH supply.

Why the contribution is important

A central bank account of patient repeat drugs due, issued and dates for med reviews and chronic disease recall dates is joining up the existing processes and disparate IT system recalls that exist just now. GPs would still use their own clinical system but the national bank card system for patient repeat drugs has economies of scale in the management, financial planning and information, across Scotland. The patient would have their own plastic ePrescription Card and just like the electricity providers an annual statement could be provided to all patients (on line) of their drug issues and (controversially) total cost for year! And...taking it a step further....like electricity comparison figures a branded v generic cost analysis could be tucked in to the end of the patients on line annual statement. Benefits to patients on long term repeats. Benefits to GPs Benefits to Directors of Pharmacies trying to better manage drug costs by improving patient awareness and helping GPs have the 'switch to generic' conversation with their patients.

by LynneClark on November 20, 2017 at 11:54PM

Current Rating

Average score : 2.0
Based on : 1 vote


  • Posted by AJ November 28, 2017 at 14:35

    this assumes the patient is in the position of going to the chemist themselves to swipe their own card, capable of managing their own medicines. in which case, yes. this could help some people. but I don't think the investment in a global system would really work for the patient population who are housebound/go out rarely or with difficulty or those whose medicines are confusing to them.

    I think we'd need to know more about the number of patients this might benefit.
Log in or register to add comments and rate ideas